Answers are grounded in this paper and cite their sources.
Population-based study reveals that olfactory dysfunction lowers quality of life in COVID-19 patients, suggesting the need for effective screening.
In our population-based cross-sectional study of 667 patients with PCR-confirmed SARS-CoV-2 infection, par-ticipants with persistent OD had significantly poorer OF-related QoL. The self-MOQ is a simple, valid and reliable means to screen OD in patients with COVID-19.
No takes yet. Share an insight, caveat, or question.
Winkelmann et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: